654471
Ali Guerami, MD — FEI 3006601423
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 1, 2010
- Fiscal Year
- 2010
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Dallas, TX (United States)
Citations
| ID | CFR | Description |
|---|
| 12225 | 21 CFR 1271.47(d) | Departures: recording and justifying |
| 12246 | 21 CFR 1271.55(d)(1)(iii) | Documentation--determination, by whom, date |
| 12409 | 21 CFR 1271.250(c) | Documentation of donor eligibility |
| 15024 | 21 CFR 1271.320(b) | Available for review and copying by FDA |